Seroquel vs. Abilify: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Seroquel and Abilify. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 343,379 people who take Seroquel and Abilify, and is updated regularly.
What is Seroquel?
Seroquel has active ingredients of quetiapine fumarate. It is often used in bipolar disorder. eHealthMe is studying from 120,285 Seroquel users. Check the latest studies of Seroquel.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.
343,379 people who take Seroquel and Abilify are studied.

Drugs being compared in this study:
- Seroquel (quetiapine fumarate)
- Abilify (aripiprazole)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Seroquel:
- not at all: 4.79 %
- somewhat: 19.72 %
- moderate: 30.69 %
- high: 30.47 %
- very high: 14.32 %
Abilify:
- not at all: 8.59 %
- somewhat: 24.11 %
- moderate: 28.51 %
- high: 25.94 %
- very high: 12.84 %
Want to compare Seroquel with Abilify?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Mati?, K., & Pele?, A. M. , "Drug-induced toxic hepatitis associated with the combination of quetiapine and fluphenazine: A case report", The European Journal of Psychiatry, 2018 Jan .
- Shah Z, Londhe V, "Influence of various media on the dissolution profiles of immediate-release quetiapine tablets in India", Dissolution Technologies, 2016 Feb .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Mati?, K., & Pele?, A. M. , "Drug-induced toxic hepatitis associated with the combination of quetiapine and fluphenazine: A case report", The European Journal of Psychiatry, 2018 Jan .
- Shah Z, Londhe V, "Influence of various media on the dissolution profiles of immediate-release quetiapine tablets in India", Dissolution Technologies, 2016 Feb .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Seroquel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Abilify:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on quetiapine fumarate and aripiprazole (the active ingredients of Seroquel and Abilify, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Amaryl and Itchiness for Men aged 50-59 - now
- Amaryl and Pruritus for Men aged 50-59 - a second ago
- Amaryl and Itching for Men aged 50-59 - a second ago
- Could Lupron cause Periodontal Disease? - 10 seconds ago
- Could Ondansetron cause Varicose Vein? - 10 seconds ago
- Colonoscopy Abnormal and drugs of ingredients of valsartan - 10 seconds ago
- Could Docetaxel cause Influenza Like Illness? - 11 seconds ago
- Could Nexavar cause Platelet Count Increased? - 12 seconds ago
- Drug interactions of Cisplatin and Meropenem - 15 seconds ago
- Could Opdivo cause Deep Venous Thrombosis? - 16 seconds ago